Basell Commence Production of Polypropylene Resins in America

Basell announced today that it has started producing its metallocene-based Metocene brand polypropylene resins in commercial scale volumes at the company’s 200 KT Spheripol process plant in Bayport, Texas, USA.

“The successful production of Metocene resins in one of our North American Spheripol assets is an important milestone for our growing Metocene business and our customers,” said Chuck Platz, president of Basell North America. “Previously these grades were only sourced in Europe. The Bayport production will also speed up the introduction of innovations that expand polypropylene’s end uses.”

Metocene grades are characterized by narrow molecular weight distribution and extreme homogeneity, which open new opportunities in melt processing. Four Metocene homopolymer grades are produced in Bayport: Two textile grades for spunbond nonwovens (MFR: 15 and 25g/10‘), one injection moulding grade (MFR: 60g/10‘) and another textile grade for meltblown fibers (MFR: 1200g/10‘). While the MFR: 15 – 60g/10’ grades have been produced on Basell’s European Spheripol process assets, the meltblown grade was produced for the first time on a commercial Spheripol line in Bayport.

“When Basell was formed, Metocene resins were only produced in Europe in one of our gasphase plants,” said Michael Mulrooney, senior vice president of Basell’s Technology Business. “We now have developed a new proprietary metallocene catalyst system for our Spheripol process that was tested on our commercial plant in Terni, Italy. The successful run in Bayport with our Avant M 101 catalyst further demonstrates our capability to use these catalysts in existing Spheripol plants.”

For more information on polypropylene, click here.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.